免疫性血小板减少-话题@MedSci

#免疫性血小板减少#

41篇内容 | 1026人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2168702, encodeId=79fc2168e02c3, content=原发性<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>症患者血小板<a href='/topic/show?id=1a7c10e4613d' target=_blank style='color:#2F92EE;'>#糖蛋白特异性抗体#</a>与短期大剂量地<a href='/topic/show?id=725310e462dd' target=_blank style='color:#2F92EE;'>#塞米松#</a>疗效及出血评分的关系, objectTitle=Hematology：原发性免疫性血小板减少症患者血小板糖蛋白特异性抗体与短期大剂量地塞米松疗效及出血评分的关系, objectType=article, longId=800885, objectId=b56d80088552, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221120/1669014360481_4754896.webp, objectUrl=/article/show_article.do?id=b56d80088552, replyNumber=0, likeNumber=31, createdTime=2023-11-15, rootId=0, userName=ms5463223, userId=dfc06407071, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b56d80088552, moduleTitle=Hematology：原发性免疫性血小板减少症患者血小板糖蛋白特异性抗体与短期大剂量地塞米松疗效及出血评分的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b56d80088552)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754090, encodeId=e6961e5409077, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Blood：黄晓军团队发现全反式维甲酸+低剂量利妥昔单抗治疗难治/复发性免疫性血小板减少症, objectType=article, longId=220605, objectId=a14b22060538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a14b22060538, replyNumber=0, likeNumber=43, createdTime=2022-03-22, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a14b22060538, moduleTitle=Blood：黄晓军团队发现全反式维甲酸+低剂量利妥昔单抗治疗难治/复发性免疫性血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a14b22060538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754093, encodeId=ba1b1e54093ba, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=BJH：免疫性血小板减少症成人在接受艾曲波帕或罗米司亭治疗后改用阿凡波帕：一项多中心美国研究, objectType=article, longId=299453, objectId=052e29945346, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=052e29945346, replyNumber=0, likeNumber=46, createdTime=2022-12-16, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=052e29945346, moduleTitle=BJH：免疫性血小板减少症成人在接受艾曲波帕或罗米司亭治疗后改用阿凡波帕：一项多中心美国研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=052e29945346)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754085, encodeId=a6031e5408508, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=NEJM：吗替麦考酚酯可作为免疫性血小板减少症患者的一线治疗, objectType=article, longId=216619, objectId=6567216619d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6567216619d2, replyNumber=0, likeNumber=36, createdTime=2022-01-08, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6567216619d2, moduleTitle=NEJM：吗替麦考酚酯可作为免疫性血小板减少症患者的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6567216619d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754089, encodeId=268b1e5408936, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=BJH：高龄患者的原发性免疫性血小板减少症表现和治疗的特殊性, objectType=article, longId=220422, objectId=c119220422a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c119220422a7, replyNumber=0, likeNumber=39, createdTime=2022-06-12, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c119220422a7, moduleTitle=BJH：高龄患者的原发性免疫性血小板减少症表现和治疗的特殊性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c119220422a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754095, encodeId=8b9f1e54095c4, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Ann Hematol：免疫性血小板减少症发展为系统性红斑狼疮的潜在危险因素：中国儿童病例对照研究, objectType=article, longId=727295, objectId=7a10e2729516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a10e2729516, replyNumber=0, likeNumber=39, createdTime=2022-08-18, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a10e2729516, moduleTitle=Ann Hematol：免疫性血小板减少症发展为系统性红斑狼疮的潜在危险因素：中国儿童病例对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a10e2729516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754094, encodeId=5c241e54094ad, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=NEJM：口服利扎鲁替尼治疗免疫性血小板减少症的疗效, objectType=article, longId=724329, objectId=ebace2432961, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebace2432961, replyNumber=0, likeNumber=66, createdTime=2022-08-20, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebace2432961, moduleTitle=NEJM：口服利扎鲁替尼治疗免疫性血小板减少症的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebace2432961)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754092, encodeId=8a911e5409226, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Clin Exp Med：免疫性血小板减少症治疗反应期间血小板活性和周转指数的变化, objectType=article, longId=295636, objectId=41b8295636aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41b8295636aa, replyNumber=0, likeNumber=48, createdTime=2022-11-02, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41b8295636aa, moduleTitle=Clin Exp Med：免疫性血小板减少症治疗反应期间血小板活性和周转指数的变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41b8295636aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754091, encodeId=48051e54091df, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Lancet Haematol：全反式视黄酸加大剂量地塞米松可作为新诊断免疫性血小板减少症患者的一线治疗, objectType=article, longId=293423, objectId=5f6429342357, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f6429342357, replyNumber=0, likeNumber=35, createdTime=2022-05-12, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f6429342357, moduleTitle=Lancet Haematol：全反式视黄酸加大剂量地塞米松可作为新诊断免疫性血小板减少症患者的一线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f6429342357)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754086, encodeId=a3ca1e54086fd, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！, objectType=article, longId=218057, objectId=abc921805e25, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abc921805e25, replyNumber=0, likeNumber=50, createdTime=2022-05-14, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abc921805e25, moduleTitle=Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abc921805e25)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754087, encodeId=95b91e54087c7, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=NEJM：疫苗诱导免疫性血小板减少症和血栓形成的临床特征, objectType=article, longId=219468, objectId=756121946838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=756121946838, replyNumber=0, likeNumber=45, createdTime=2022-08-21, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=756121946838, moduleTitle=NEJM：疫苗诱导免疫性血小板减少症和血栓形成的临床特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=756121946838)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754088, encodeId=fb331e54088e8, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Blood Cells Mol Dis：艾曲波帕作为原发性免疫性血小板减少症患者二线治疗的有效性和安全性, objectType=article, longId=219573, objectId=1bc72195e3c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bc72195e3c8, replyNumber=0, likeNumber=46, createdTime=2022-02-23, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bc72195e3c8, moduleTitle=Blood Cells Mol Dis：艾曲波帕作为原发性免疫性血小板减少症患者二线治疗的有效性和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bc72195e3c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754083, encodeId=b9a61e54083d1, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Rozanolixizumab治疗原发性免疫性血小板减少症：II期研究取得积极进展, objectType=article, longId=200483, objectId=a181200483f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a181200483f7, replyNumber=0, likeNumber=45, createdTime=2021-04-01, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a181200483f7, moduleTitle=Rozanolixizumab治疗原发性免疫性血小板减少症：II期研究取得积极进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a181200483f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754084, encodeId=0efd1e54084f4, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=BTK抑制剂Rilzabrutinib治疗免疫性血小板减少症：被授予FDA快速通道指定, objectType=article, longId=203551, objectId=920d203551ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920d203551ad, replyNumber=0, likeNumber=35, createdTime=2020-11-30, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920d203551ad, moduleTitle=BTK抑制剂Rilzabrutinib治疗免疫性血小板减少症：被授予FDA快速通道指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=920d203551ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754082, encodeId=92851e54082fa, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Brit J Heamatol：免疫性血小板减少症儿童和青少年疲劳状况, objectType=article, longId=196747, objectId=6da7196e47c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6da7196e47c3, replyNumber=0, likeNumber=29, createdTime=2021-05-06, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6da7196e47c3, moduleTitle=Brit J Heamatol：免疫性血小板减少症儿童和青少年疲劳状况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6da7196e47c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754079, encodeId=62641e54079e2, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=2019 ASH指南：免疫性血小板减少症, objectType=article, longId=184512, objectId=e27518451236, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e27518451236, replyNumber=0, likeNumber=33, createdTime=2020-07-30, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e27518451236, moduleTitle=2019 ASH指南：免疫性血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e27518451236)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754081, encodeId=328d1e54081ce, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Brit J Heamatol：免疫性血小板减少症对儿童疲劳、执行功能和心理的影响, objectType=article, longId=193398, objectId=62cf19339899, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62cf19339899, replyNumber=0, likeNumber=45, createdTime=2021-02-10, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62cf19339899, moduleTitle=Brit J Heamatol：免疫性血小板减少症对儿童疲劳、执行功能和心理的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62cf19339899)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754080, encodeId=e0c21e5408043, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=J Thromb Haemost：免疫性血小板减少症儿童抗血小板抗体的预后意义, objectType=article, longId=188113, objectId=60e418811305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60e418811305, replyNumber=0, likeNumber=34, createdTime=2020-12-02, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60e418811305, moduleTitle=J Thromb Haemost：免疫性血小板减少症儿童抗血小板抗体的预后意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60e418811305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754077, encodeId=fc291e54077ab, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=罕见病例1例|原发性胆汁性胆管炎合并干燥综合征及免疫性血小板减少症, objectType=article, longId=178171, objectId=2f7c1e81717b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f7c1e81717b, replyNumber=0, likeNumber=37, createdTime=2019-12-03, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f7c1e81717b, moduleTitle=罕见病例1例|原发性胆汁性胆管炎合并干燥综合征及免疫性血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f7c1e81717b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754076, encodeId=df4b1e540763f, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=J Thromb Haemost：慢性免疫性血小板减少症患者心血管和出血结局, objectType=article, longId=163695, objectId=e77c163695e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e77c163695e7, replyNumber=0, likeNumber=33, createdTime=2019-06-13, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e77c163695e7, moduleTitle=J Thromb Haemost：慢性免疫性血小板减少症患者心血管和出血结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e77c163695e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫性血小板减少

2020-05-29

ms5463223 (审核中...)

前往app查看评论内容

原发性#免疫性血小板减少#症患者血小板#糖蛋白特异性抗体#与短期大剂量地#塞米松#疗效及出血评分的关系

Hematology：原发性免疫性血小板减少症患者血小板糖蛋白特异性抗体与短期大剂量地塞米松疗效及出血评分的关系

2023-11-15发表于上海

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Blood：黄晓军团队发现全反式维甲酸+低剂量利妥昔单抗治疗难治/复发性免疫性血小板减少症

2022-03-22

hb2008ye (审核中...)

前往app查看评论内容

#免疫性血小板减少#

BJH：免疫性血小板减少症成人在接受艾曲波帕或罗米司亭治疗后改用阿凡波帕：一项多中心美国研究

2022-12-16

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

NEJM：吗替麦考酚酯可作为免疫性血小板减少症患者的一线治疗

2022-01-08

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

BJH：高龄患者的原发性免疫性血小板减少症表现和治疗的特殊性

2022-06-12

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Ann Hematol：免疫性血小板减少症发展为系统性红斑狼疮的潜在危险因素：中国儿童病例对照研究

2022-08-18

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

NEJM：口服利扎鲁替尼治疗免疫性血小板减少症的疗效

2022-08-20

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Clin Exp Med：免疫性血小板减少症治疗反应期间血小板活性和周转指数的变化

2022-11-02

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Lancet Haematol：全反式视黄酸加大剂量地塞米松可作为新诊断免疫性血小板减少症患者的一线治疗

2022-05-12

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Lancet Haemat：全反式维甲酸+大剂量地塞米松或可成为原发性免疫性血小板减少症的新一线疗法！

2022-05-14

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

NEJM：疫苗诱导免疫性血小板减少症和血栓形成的临床特征

2022-08-21

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Blood Cells Mol Dis：艾曲波帕作为原发性免疫性血小板减少症患者二线治疗的有效性和安全性

2022-02-23

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Rozanolixizumab治疗原发性免疫性血小板减少症：II期研究取得积极进展

2021-04-01

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

BTK抑制剂Rilzabrutinib治疗免疫性血小板减少症：被授予FDA快速通道指定

2020-11-30

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Brit J Heamatol：免疫性血小板减少症儿童和青少年疲劳状况

2021-05-06

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

2019 ASH指南：免疫性血小板减少症

2020-07-30

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Brit J Heamatol：免疫性血小板减少症对儿童疲劳、执行功能和心理的影响

2021-02-10

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

J Thromb Haemost：免疫性血小板减少症儿童抗血小板抗体的预后意义

2020-12-02

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

罕见病例1例|原发性胆汁性胆管炎合并干燥综合征及免疫性血小板减少症

2019-12-03

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

J Thromb Haemost：慢性免疫性血小板减少症患者心血管和出血结局

2019-06-13

科室
- - 订阅+
  - 更多科室
工具
服务